Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Jun;7(2):163-70.
doi: 10.1007/s12105-012-0385-0. Epub 2012 Jul 31.

Carcinosarcoma ex non-recurrent pleomorphic adenoma composed of TTF-1 positive large cell neuroendocrine carcinoma and myofibrosarcoma: apropos a rare Case

Affiliations
Case Reports

Carcinosarcoma ex non-recurrent pleomorphic adenoma composed of TTF-1 positive large cell neuroendocrine carcinoma and myofibrosarcoma: apropos a rare Case

Fredrik Petersson et al. Head Neck Pathol. 2013 Jun.

Abstract

We present a carcinosarcoma ex non-recurrent pleomorphic adenoma composed of a large cell neuroendocrine carcinomatous component and a spindle cell sarcoma with myofibroblastic differentiation. The tumor contained a hyalinized transition zone where the classical PA appeared to acquire two different histopathological patterns of malignant transformation of the epithelial component. The carcinomatous component was strongly and diffusely positive for low-molecular weight cytokeratins (AE1-3), synaptophysin, thyroid transcription factor-1 and focally positive for chromogranin A. All these markers were negative in the sarcomatous component. The sarcomatous component displayed immunoreactivity for smooth muscle actin with a predominantly linear, subplasmalemmal pattern. No expression of CD31, S100 protein, h-caldesmon, desmin, CD34, p63, myogenin, Myo D1 and c-kit was detected. Strong immunohistochemical expression of p53 was documented in both the carcinomatous and sarcomatous components as well as in the atypical epithelial component in the transition zone associated with the hyalinized pleomorphic adenoma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Photomicrograph of the gross surgical specimen showing a relatively well circumscribed tumor with a whitegray to tan cut surface. Large parts of the tumor showed haemorrhagic necrosis
Fig. 2
Fig. 2
Haematoxylin and eosin stained sections revealed a distinctly biphasic appearance with a nested, carcinomatous component intimately intermingled with a spindle cell, sarcomatous component (a). The carcinomatous component showed high-grade malignant histological features including prominent nuclear atypia, high nuclear to cytoplamic ratio and abundant mitotic activity (b). The sarcomatous component displayed significant nuclear atypia and mitotic activity, including atypical forms (arrow; c). Areas with the classical features of a pleomorphic adenoma were present (d). The pleomorphic adenoma was associated with areas of hyalinization. The hyalinized areas of the pleomorphic adenoma (right) merged with a component of the tumor that had a “less orderly” appearance (left; e). This “less orderly” area contained a clearly atypical epithelial component. The epithelium displayed in addition to nuclear atypia a clear to vacuolated cytoplasm and a mostly readily identifiable peripheral myoepithelial layer (f). A mammary type of intraductal dysplasia/ductal carcinoma in situ-like proliferation which was invested by myoepithelial cells was also identified (g)
Fig. 3
Fig. 3
Photomicrographs from the immunohistochemical study showing that the carcinomatous component was positive for cytokeratins (a), synaptophysin (b) and TTF-1 (c), while the sarcomatous component was negative. The sarcomatous component displayed immunoreactivity for SMA (d). The presence of smooth muscle actin positive myoepithelial cells displayed a gradual reduction to complete absence in the atypical epithelial component in the hyalinized area (e)

Similar articles

Cited by

References

    1. Gnepp DR. Malignant mixed tumors of the salivary glands: a review. Pathol Annu. 1993;28(Pt 1):279–328. - PubMed
    1. Gnepp DR. WHO classification of tumors. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics. Head and neck tumors. Lyon: IARC Press; 2005.
    1. Ueo T, Kaku N, Kashima K, et al. Carcinosarcoma of the parotid gland: an unusual case with large-cell neuroendocrine carcinoma and rhabdomyosarcoma. Apmis. 2005;113:456–464. doi: 10.1111/j.1600-0463.2005.apm_231.x. - DOI - PubMed
    1. Kirklin JW, Mc DJ, Harrington SW, et al. Parotid tumors: histopathology, clinical behavior, and end results. Surg Gynecol Obstet. 1951;92:721–733. - PubMed
    1. Weiler C, Zengel P, van der Wal JE, et al. Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases. Histopathology 2011;59:741–50. - PubMed

Publication types

MeSH terms